AB
AH Bio Fund II, L.P.
DELAYED 1 MONTH
10% Owner
Nautilus Biotechnology, Inc.
Scribe Therapeutics, Inc.
Filings
2
Companies
2
Latest
Jul 27, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
—
Scribe Therapeutics, Inc.
AH Bio Fund II, L.P.
10% Owner
Purchase
$5.0M
333,333 sh
Jul 29 11:09 PM
Jul 27, 2026
—
Nautilus Biotechnology, Inc.
AH Bio Fund II, L.P.
10% Owner
Sale
$11.8M
5,000,000 sh
Jun 4 8:53 PM
Jun 2, 2026